Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.00
Bid: 17.00
Ask: 17.98
Change: 0.00 (0.00%)
Spread: 0.98 (5.765%)
Open: 17.00
High: 17.00
Low: 17.00
Prev. Close: 17.00
NANO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Development Agreement

23 Sep 2009 07:00

RNS Number : 4997Z
Nanoco Group PLC
23 September 2009
 
For immediate release
23 September 2009
 
 
NANOCO GROUP PLC
(“Nanoco” or “the Company”)
 
Signs Agreement with Major Japanese Electronics Company
Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of commercial quantities of quantum dots, announces that it has signed a joint development agreement with a major Japanese electronics company under which it will design and develop quantum dots for use in light emitting diodes (LEDs) in liquid crystal display (LCD) televisions. 
Nanoco will receive an upfront payment and milestone payments under the terms of the agreement and, on completion of the 18-month development work, it is expected that a supply and licence agreement will be signed. 
The structure of this agreement is similar to an earlier agreement with another major Japanese corporation active in the LCD display and general lighting markets. The earlier agreement comprised a total of $1.2 million in joint development payments during a 12-month period. The development work was successful and a supply and licence agreement followed, from which a further US$8 million in milestone payments is expected by 31 December 2010.
It is anticipated that Nanoco will sign further agreements with companies active in the LED market in due course. 
The use of LEDs as the backlight for LCD displays and in general lighting allows a substantial reduction in the power consumed. Quantum dots offer key advantages over the phosphors currently used to create white light from LEDs including superior colour performance. 
Michael Edelman, Nanoco’s Chief Executive Officer, commented: “We are delighted to enter into this agreement with a major company aimed at using our quantum dots in LCD TVs. This follows an earlier agreement with another major corporation, which is progressing well. We anticipate signing further deals in the LED market. This represents just one of the key areas in which we are making rapid progress in the commercialisation of our quantum dot development, scale up and manufacturing technology.”
For further information please contact:
 
Nanoco
+ 44 (0) 161 603 7900
Michael Edelman, Chief Executive Officer
 
 
 
Zeus Capital
+ 44 (0) 161 831 1512
Alex Clarkson
 
Nick Cowles
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Jennie Spivey / Miranda Higham 
 
 
 
Notes for editors:
 
About Nanoco Group plc
Nanoco is a world leader in the development and manufacture of commercial quantities of quantum dots for use in multiple applications including solid-state lighting, solar cells and biological imaging.Nanoco’s quantum dots, which are free of heavy metals and comply with RoHS legislation, can be combined into a wide range of materials including liquids, polymers and glass.
 
Nanoco forms strategic partnerships with major end users across a range of applications.
 
Nanoco was founded in 2001 and is based in Manchester, UK. It also has an office in Tokyo, Japan. Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO.
 
About quantum dots
Quantum dots are fluorescent nano-sized particles of semiconductor material which have the ability to emit light in a specific colour dependent on the size of the particle.
 
 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRDGGZLLZRGLZM
Date   Source Headline
8th Oct 20211:48 pmRNSNotice of Results
19th Aug 20217:00 amRNSNon-Executive Director Appointment
16th Jul 20214:41 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
15th Jul 20217:00 amRNSNon-dilutive loan note subscription
5th Jul 20217:30 amRNSDevelopment Agreement
28th Jun 20217:00 amRNSLitigation update and non-dilutive debt facility
10th Jun 202111:33 amRNSBlocklisting Six-Monthly Return
24th May 202112:20 pmRNSHolding(s) in Company
20th May 20217:00 amRNSLitigation Update
13th May 20217:00 amRNSProject Extension
12th May 20217:00 amRNSLitigation Update
6th May 20213:28 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSInterim Results
29th Mar 20217:00 amRNSLitigation Update
26th Mar 20214:41 pmRNSSecond Price Monitoring Extn
26th Mar 20214:36 pmRNSPrice Monitoring Extension
24th Mar 20213:36 pmRNSAmendment to Executive Director Service Terms
16th Mar 20212:30 pmRNSNotice of Results
10th Feb 20214:40 pmRNSSecond Price Monitoring Extn
10th Feb 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20214:41 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
21st Dec 20207:00 amRNSDirector/PDMR Shareholding
11th Dec 202011:40 amRNSBlocklisting Six-Monthly Return
3rd Dec 202012:10 pmRNSResult of AGM
3rd Dec 20207:00 amRNSAGM Statement
25th Nov 20207:00 amRNSGrant Funding Award for Life Sciences Project
17th Nov 20205:50 pmRNS2020 Annual Report and Notice of AGM
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
21st Oct 20203:16 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSPreliminary Results
7th Oct 20207:00 amRNSNotice of Results
25th Sep 20204:36 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSDirectorate Changes
21st Jul 202011:25 amRNSHolding(s) in Company
20th Jul 202012:35 pmRNSHolding(s) in Company
16th Jul 20202:15 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSResult of Fund Raise
15th Jul 20205:20 pmRNSPrimaryBid.com Offer
15th Jul 20205:17 pmRNSTrading Update and Proposed Fundraising
14th Jul 20209:55 amRNSHolding(s) in Company
13th Jul 20207:00 amRNSLitigation Funding Agreement
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
30th Jun 202010:06 amRNSHolding(s) in Company
9th Jun 20207:00 amRNSBlocklisting Six-Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.